the eczema was an allergic reaction samples of four chemicals used in the production of Softexe were obtained from the manufacturers (Cuxson, Gerrard and Co Ltd). Patch tests were applied using Finn chambers under Scanpor. Each ingredient was applied neat and also in 10 0 and 1 ", dilutions in yellow soft paraffin. Additional patch tests were performed on each patient to the European standard battery and to Gypsona, benzalkonium chloride, cetrimide, and Softexe wool. They were read 48 and 96 hours after application. All six patients developed allergic reactions to Softexe, while three were also allergic to Gypsona, benzalkonium chloride, and cetrimide (table) . Of the Softexe ingredients tested, only one (sodium dioctyl sulphosuccinate, also known as Clestol) produced an allergic reaction; this occurred in all six patients. Four patients developed an allergic reaction to a 1 % solution of Clestol. Neat Clestol also produced an irritant reaction in all cases. None of the three other chemicals produced allergic reactions.
Eight normal subjects and 10 with non-inflammatory skin disease were patch tested to neat Clestol and to 10°, and 1 0( dilutions of this substance.
Neat Clestol produced an irritant reaction in 12 of the 18 subjects; the 10 00 and 1 0" dilutions caused neither irritant nor allergic reactions.
Comment
Softexe is a fairly new lining bandage used beneath plaster casts and is usually placed in direct contact with the skin. Its properties permit comfortable, firm application of various self-setting cast materials. Among its constituents, which include wetting agents and an acrylic binder, is an anionic surfactant called Clestol (sodium dioctyl sulphosuccinate). This is a known contact allergen.' Contact allergy to benzalkonium chloride in Gypsona has been described.2 Three of the patients in our series were also allergic to this substance. Cross-sensitisation has been observed between benzalkonium chloride and other quaternary ammonium compounds-for example, cetri- Failure to recognise contact allergy after prolonged occlusive contact may lead to secondary infected eczema, cellulitis, or even infected fractures, though no major complication has yet been seen. The itching, pain, and sweating resulting from contact dermatitis beneath a constricted cast or bandage may occur at any time from a few days to several weeks after application. The symptoms and signs are easy to confuse with those due to constriction or friction caused by the cast. Simply splitting or replacing the cast will not be sufficient treatment. If the diagnosis is suspected the entire cast and lining bandage should be removed, subject to the necessary treatment for the fracture, when different splinting materials should be used. Exposure is usually sufficient for treating the rash, though a mild topical steroid may be necessary.
Contact allergy, though rare, may be avoided by eliminating allergens from cast materials. The manufacturers have told us that a new formulation of Softexe is being prepared without Clestol.
We are grateful to Messrs Cuxson, Gerrard and Co (Dressings) Ltd for their co-operation and to Mrs Janet Owen for help in preparing this paper. Captopril-associated lymphadenopathy
Captopril, a converting-enzyme inhibitor, is now being used increasingly to treat arterial hypertension and congestive cardiac failure.' Severe side effects of the drug, such as proteinuria2 and agranulocytosis,3 have been reported. We report two cases of reversible lymphadenopathy in patients treated with captopril.
Case reports
Case 1-A 37-year-old woman had had untreated hypertension for five months. She had had no previous important illnesses and, apart from her raised blood pressure, physical examination and laboratory tests showed nothing abnormal. After six weeks of treatment with captopril 300 mg daily as the only antihypertensive agent she was admitted to hospital with painful lymph nodes in both groins, the left axilla, and the neck. The liver and spleen were not palpable. Leucocyte count was 46 x109/1, with 25% eosinophils. Erythrocyte sedimentation rate was 3 mm in the first hour, and immunoglobulins, antinuclear antibodies, and complement titres were normal. Liver enzyme activities were also normal. Microscopic examination of the enlarged lymph nodes showed unspecified adenitis. A chest x-ray film was normal. Captopril was immediately withdrawn, and within two weeks the lymph nodes were not palpable and the eosinophil count was normal.
Case 2-A 47-year-old man had had primary hypertension for five years. He had no known liver disease, and liver enzyme activities were normal before he received captopril. His blood pressure became normal with 150 mg of captopril daily and for three months all laboratory tests were normal. He was subsequently admitted with painful palpable lymph nodes in both groins, the left axilla, and the back of the right knee. His temperature was 38 3°C. The leucocyte count was 6 x 109/1, with 50o eosinophils. Erythrocyte sedimentation rate was 6 mm in the first hour. Serum aspartate and alanine transferase activities were slightly raised (0.90 tLkat/l, normal < 0-75).
Captopril was immediately withdrawn. After one week the lymph nodes were not palpable and all laboratory tests were normal.
Comment
The lack of any previous disease of the lymphatic system in these two patients and the rapid recovery within a few days of withdrawal of the drug suggest a drug-related lymphadenopathy. 
Patients, methods, and results
Patients were included in the study ifthey were attending an ophthalmology clinic for the treatment of complications one year or more after an attack of herpes zoster ophthalmicus. All but one were known to have received the standard recommended form of treatment for herpes zoster ophthalmicus4 early in the disease: an intensive course of topical antibiotics and corticosteroids was given during admission to hospital for about one week and antiglaucoma treatment and artificial tear preparations were provided if required. Low-dose topical steroids were subsequently continued for several months on an outpatient basis. Information about the initial treatment in case 13 was not available.
Assessment of each patient included measurement of visual acuity, intraocular pressure, and tear production, as well as ophthalmoscopy and examination with a slit-lamp biomicroscope.
A progressive reduction in visual acuity was found in 11 of the 13 patients (table); in five patients vision was reduced to finger counting, hand movements, or perception of light, and one patient (case 11) had his eye excised. The major complication, found in nine patients, was loss of corneal-sensation associated with recurrent keratitis and scarring of the cornea. The eyelids of five of these patients (cases 6, 8, 10, 11, and 12 ) required suturing (tarsorrhaphy) to protect their anaesthetic corneas. Despite tarsorrhaphy the neuroparalytic keratitis in two of these patients resulted in spontaneous perforation of the eye. One of these, a 40-year-old woman (case 8) with systemic lupus erythematosus requiring treatment with systemic steroids, developed perforation of the cornea 20 months after the attack of herpes zoster ophthalmicus. By the time of this survey she had received three corneal grafts and undergone a cataract extraction and an operation for glaucoma. The second patient, an 88-year-old man (case 11), developed a corneal abscess and spontaneous perforation that necessitated excision of the eye 22 months after the onset of herpes zoster ophthalmicus. Chronic glaucoma and recurrent uveitis were found in seven patients; in one of them (case 13) these complications were still requiring treatment 23 years after the onset of herpes zoster ophthalmicus. In three of these patients (cases 8, 9, 13) associated cataracts resulted in severe visual impairment. Scarring of the eyelids and eyelash abnormalities (trichiasis) were not major complications except in one patient (case 2), who required four plastic surgery procedures for cicatricial ectropion of the upper lid. Three patients (cases 4, 5, 8) complained of persistent postherpetic neuralgia.
Comment
Spontaneous perforation of an anaesthetic cornea has been described as a frequent complication of herpes zoster ophthalmicus, often requiring excision of the eye.1 Since the introduction of modern therapeutic methods perforation of the eye has become a rare complication: in a series of over 500 patients presenting with herpes zoster ophthalmicus only one subsequently sustained perforation of an eye and this responded satisfactorily to medical treatment.3 In the present study perforation of the eye occurred in two patients, one of them elderly and the other immunologically compromised.
Both patients required extensive surgical intervention, the older patient having the eye excised. The late occurrence of corneal perforation, nearly two years after the onset of herpes zoster ophthalmicus, suggests that patients in these categories should be carefully followed up for a long time. Glaucoma and recurrent uveitis may similarly require treatment for an extended period after the initial episode of herpes zoster ophthalmicus.
I thank the consultant ophthalmologists at Coventry and Warwickshire
Hospital for permission to report on their patients, and Dr Heather M Beaumont for help in preparing the manuscript.
